More about
Gastrointestinal Neuroendocrine Carcinomas
News
February 27, 2024
2 min watch
Save
VIDEO: Nab-paclitaxel shows promise for treatment of neuroendocrine tumors
In this video, Laleh Melstrom, MD, MS, discusses results from the NABNEC study, a randomized phase 2 study of nab-paclitaxel in combination with carboplatin as first-line treatment of gastrointestinal neuroendocrine carcinomas.